Extracorporeal shock wave therapy for plantar fasciitis: randomised controlled multicentre trial

Unfortunately many of these applications were not tested through appropriate randomised clinical trials or practical clinical trials, which could adequately assess clinical efficacy and significant modification of the natural history of a given musculoskeletal disorder. In 1995 the Food and Drug Adm...

Full description

Saved in:
Bibliographic Details
Published in:British journal of sports medicine 2004-08, Vol.38 (4), p.382-382
Main Author: Ogden, J A
Format: Article
Language:English
Subjects:
Clinical trials
extracorporeal shock wave treatment
Fasciitis, Plantar - therapy
FDA approval
foot
Humans
Lithotripsy - methods
Methods
Multicenter Studies as Topic
Patient satisfaction
plantar fasciitis
randomised control trial
Randomized Controlled Trials as Topic
Shock waves
Sports injuries
Studies
Therapy
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Unfortunately many of these applications were not tested through appropriate randomised clinical trials or practical clinical trials, which could adequately assess clinical efficacy and significant modification of the natural history of a given musculoskeletal disorder. In 1995 the Food and Drug Administration (FDA) in the United States approved the initial studies to evaluate the application of a device specifically redesigned to apply extracorporeal (transcutaneous) shock waves to chronic plantar fasciopathy (fasciitis).
ISSN:0306-3674
1473-0480
DOI:10.1136/bjsm.2004.011601